TG Therapeutics, Inc.TGTXNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$41.93M
↑ 130% above average
Average (9y)
$-137.84M
Historical baseline
Range
High:$41.93M
Low:$-344.77M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $41.93M | +103.2% |
| 2023 | $20.63M | +109.5% |
| 2022 | $-218.32M | +36.7% |
| 2021 | $-344.77M | -26.0% |
| 2020 | $-273.59M | -61.8% |
| 2019 | $-169.06M | +3.1% |
| 2018 | $-174.40M | -46.9% |
| 2017 | $-118.71M | -50.3% |
| 2016 | $-78.97M | -25.0% |
| 2015 | $-63.18M | - |